COMMUNIQUÉ DE PRESSE publié le 25/11/2025 à 17:15, il y a 27 jours 15 heures SMX Redefines Gold's Transformative Future at DMCC SMX (NASDAQ:SMX) to showcase identity verification solutions at 2025 DMCC Precious Metals Conference. Transforming gold market operations with Physical to Digital Link technology for global trade. Dubai's DMCC plays key role in supporting SMX's initiative Identity Verification Gold Market SMX DMCC Precious Metals Conference Dubai DMCC
COMMUNIQUÉ DE PRESSE publié le 25/11/2025 à 17:00, il y a 27 jours 15 heures Form 8.3 - Zürcher Kantonalbank: Cicor Technologies Ltd. Zürcher Kantonalbank discloses a 1.04% interest in Cicor Technologies Ltd. according to Form 8.3. No other parties involved in the disclosure Form 8.3 Disclosure Zürcher Kantonalbank Cicor Technologies Ltd. 1.04% Interest
COMMUNIQUÉ DE PRESSE publié le 25/11/2025 à 16:48, il y a 27 jours 15 heures Enapter AG: Rights issue capital increase launched as part of capital measure totaling €12 million – full placement secured Enapter AG launches a rights issue capital increase of €12 million, ensuring full placement. Funding aims for break-even in 2026 with support from institutional shareholders Capital Increase Rights Issue Enapter AG Institutional Shareholders Break-even 2026
COMMUNIQUÉ DE PRESSE publié le 25/11/2025 à 16:31, il y a 27 jours 16 heures Turkiye Garanti Bankasi A.S.: Brokerage Houses Warrants Initial Sale Prices Turkiye Garanti Bankasi A.S. to list 920 million Brokerage House warrants on Borsa Istanbul A.S. Structured Products and Funds Market with initial sale prices. Prices may change after trading begins on 25.11.2025 Warrants Turkiye Garanti Bankasi A.S. Initial Sale Prices Brokerage Houses Borsa Istanbul A.S.
COMMUNIQUÉ DE PRESSE publié le 25/11/2025 à 16:26, il y a 27 jours 16 heures SMX Presents at the 2025 DMCC Precious Metals Conference as the Gold Market Shifts Toward Full Traceability SMX to showcase Physical-to-Digital Link technology at DMCC Precious Metals Conference, enhancing transparency, traceability, and authenticity in gold and silver markets Technology Transparency Precious Metals Traceability SMX
COMMUNIQUÉ DE PRESSE publié le 25/11/2025 à 15:51, il y a 27 jours 16 heures Final Offer Price Notification ISIN XS2999244671 BNP Paribas Issuance B.V. notifies final offer price of unsubordinated notes. Subscription dates and prices detailed in the press release BNP Paribas EU Regulation Final Offer Price Unsubordinated Notes Subscription Dates
COMMUNIQUÉ DE PRESSE publié le 25/11/2025 à 15:48, il y a 27 jours 16 heures Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated The Vanguard Group, Inc. discloses 10.68% ownership in Qualcomm Incorporated. Recent dealings include purchases and sales of USD 0.0001 common securities Securities Dealings Vanguard Group Ownership Disclosure Stock Transactions Qualcomm Incorporated
COMMUNIQUÉ DE PRESSE publié le 25/11/2025 à 15:47, il y a 27 jours 16 heures Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc. The Vanguard Group, Inc. discloses 7.47% ownership in American Axle & Manufacturing Holdings, Inc. as of 24 November 2025 The Vanguard Group Ownership Disclosure Financial Investment Stock Holdings American Axle & Manufacturing Holdings
COMMUNIQUÉ DE PRESSE publié le 25/11/2025 à 15:47, il y a 27 jours 16 heures Final Offer Price Notification ISIN XS2999244754 Final Offer Price Notification for BNP Paribas Issuance B.V. Unsubordinated Notes under EU Regulation 2017/1129 with ISIN XS2999244754. Subscription details and dates included EU Regulation 2017/1129 Final Offer Price Notification BNP Paribas Issuance B.V. ISIN XS2999244754 Subscription Details
COMMUNIQUÉ DE PRESSE publié le 25/11/2025 à 15:46, il y a 27 jours 16 heures Form 8.3 - The Vanguard Group, Inc.: JTC plc The Vanguard Group, Inc. discloses a 5.06% stake in JTC plc as of 24 Nov 2025. Details include owning 8,696,122 relevant securities and recent purchase/sale transactions Relevant Securities The Vanguard Group Stake Disclosure JTC Plc Purchase/sale Transactions
Publié le 22/12/2025 à 18:33, il y a 14 heures 12 minutes ABEO SE RENFORCE ET OBTIENT UNE TRÈS LARGE MAJORITÉ DU CAPITAL DE VOGO AVEC 90,84% DÉTENUS À L’ISSUE DE L’OFFRE RÉOUVERTE
Publié le 22/12/2025 à 18:05, il y a 14 heures 41 minutes Covivio - Treasury shares transactions between December 15th , 2025 and December 19th, 2025
Publié le 22/12/2025 à 18:05, il y a 14 heures 41 minutes Covivio - Déclaration des transactions sur actions propres réalisées du 15 décembre au 19 décembre 2025
Publié le 22/12/2025 à 17:45, il y a 15 heures 1 minute Déclaration des transactions sur actions propres réalisées du 15 au 19 décembre 2025 dans le cadre du programme de rachat d’actions
Publié le 22/12/2025 à 17:35, il y a 15 heures 11 minutes DECLARATION HEBDOMADAIRE D'OPERATIONS EFFECTUEES DU 15 AU 19 DECEMBRE 2025
Publié le 23/12/2025 à 03:00, il y a 5 heures 46 minutes Forte Group Receives BC Liquor Co-Packing Licence, Expanding Beverage Alcohol and Zero-Proof Manufacturing Capabilities at Its British Columbia Beverage Manufacturing Facility
Publié le 22/12/2025 à 23:35, il y a 9 heures 11 minutes Cypher Metaverse Inc. Announces Closing of Financing
Publié le 22/12/2025 à 23:05, il y a 9 heures 41 minutes BlackBerry to Host Investor Briefing at CES 2026
Publié le 22/12/2025 à 22:50, il y a 9 heures 56 minutes American Critical Minerals Clarifies Technical Disclosure
Publié le 22/12/2025 à 22:35, il y a 10 heures 11 minutes NioCorp to Begin Construction of Mine Portal at Its Elk Creek Critical Minerals Project
Publié le 23/12/2025 à 08:30, il y a 15 minutes Anemoi International Ltd: KYC/AML subsidiary id4 signs new reseller contract
Publié le 23/12/2025 à 08:21, il y a 24 minutes EQS-Adhoc: Brockhaus Technologies AG: Sale of the stake in the Bikeleasing Group
Publié le 23/12/2025 à 07:00, il y a 1 heure 45 minutes Xlife Sciences AG Announces Transition to the Main Segment of SIX Swiss Exchange to Strengthen Market Presence
Publié le 23/12/2025 à 07:00, il y a 1 heure 45 minutes MindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Next-Generation Therapeutics